An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

PAR-25-184 - Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity	NOT-OD-22-135	ONR, FIC, NCI, NHLBI, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NIMHD, NINR, OAR, OBSSR, ODP, ODS, PN, ORWH	Jun 21, 2022	Nov 29, 2024	R01, 333, R21, K01, R34, R33, R61/R33, UG3/UH3, K43
Notice of Special Interest: NIMH Priorities on Research on Aggression and Violence Against Others	NOT-MH-22-095	NIMH	Feb 3, 2022	Jan 8, 2025	R36, R01, R34, R21, F32, R21/R33, R03, R61/R33, U01, K08, R15, K23, P50, F30, K99/R00, F31, K22, K01

For technical issues E-mail OER Webmaster

Redirect Notice

PAR-25-184 - Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Stay Connected

Government Sites

Web Policies and Notices

Site Map